selected publications
- Neoadjuvant Non-Ablative SBRT Plus Immunotherapy Yields Similar Pathologic Response as Chemo-Immunotherapy in Non-Small Cell Lung Cancer. The Journal of thoracic and cardiovascular surgery. 2025 Academic Article GET IT
- Next generation performance status: digital health technologies across the lung cancer continuum. Frontiers in digital health. 2025 Review GET IT
- Disparities in adherence to guideline-concordant care and receipt of immunotherapy for Non-Small cell lung cancer in the United States. Lung cancer (Amsterdam, Netherlands). 2025 Academic Article GET IT
- The Evolving Role of Lymph Node Resection in the Era of Immunotherapy for NSCLC. Seminars in thoracic and cardiovascular surgery. 2025 Editorial Article GET IT
- Tumor-specific draining lymph node CD8 T cells orchestrate an anti-tumor response to neoadjuvant PD-1 immune checkpoint blockade. 2025 GET IT
- All segments are created equal: locoregional recurrence and survival after single versus multi-segment resection in patients with clinical stage IA ≤ 2 cm non-small cell lung cancer. European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery. 2025 Academic Article GET IT
- Does High Standard Uptake Value on Positron Emission Tomography Preclude Sublobar Resection in Stage IA Non-Small Cell Lung Cancer ≤2cm?. The Annals of thoracic surgery. 2024 Academic Article GET IT
- A robotic-assisted thymectomy is equivalent to a transsternal resection in large thymomas. Journal of thoracic disease. 2024 Academic Article GET IT
- Epidemiological Study of Adenoid Cystic Carcinoma and Its Outcomes: Insights from the Surveillance, Epidemiology, and End Results (SEER) Database. Cancers. 2024 Academic Article GET IT
- Staged, robotic video-assisted thoracoscopic surgical approach to treat dysphagia lusoria. 2024 GET IT
- Wedge resection, segmentectomy, and lobectomy: oncologic outcomes based on extent of surgical resection for ≤2 cm stage IA non-small cell lung cancer. Journal of thoracic disease. 2024 Academic Article GET IT
-
Survival difference among adult and pediatric mediastinal yolk sac tumors cases: A meta-analysis of case reports.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
2024
Review
GET IT
Times cited: 4 - Should Sampling of Three N2 Stations be a Quality Metric for Curative Resection of Stage I Lung Cancer?. The Journal of thoracic and cardiovascular surgery. 2023 Academic Article GET IT
- Sowing the Seeds of Evasion: Lung Adenocarcinoma Plans Its Escape. Annals of surgical oncology. 2023 Editorial Article GET IT
- Tumor-targeted non-ablative radiation promotes solid tumor CAR T-cell therapy efficacy. Cancer immunology research. 2023 Academic Article GET IT
-
Surgical Treatment at an Academic Medical Center is Associated with Statistically Insignificant Lung Cancer Survival Outcome Differences Related to ZIP Code.
World journal of surgery.
2023
Academic Article
GET IT
Times cited: 28 - Commentary: Neoadjuvant immune checkpoint monotherapy for lung cancer: Has the train left the station?. The Journal of thoracic and cardiovascular surgery. 2022 Editorial Article GET IT
- Ten-year Survival and Recurrence Patterns after Three-field Lymph Node Dissection for Squamous Cell and Adenocarcinoma of the Esophagus. Annals of surgery. 2022 Academic Article GET IT
- Adjuvant therapy for early-stage non-small cell lung cancer: The breaking of a new dawn. The Journal of thoracic and cardiovascular surgery. 2022 Editorial Article GET IT
-
Extent of Resection Influences Survival in Early-Stage Lung Cancer With Occult Nodal Disease.
The Annals of thoracic surgery.
2022
Academic Article
GET IT
Times cited: 8 - Imaging CAR T-cell kinetics in solid tumors: Translational implications. Molecular therapy oncolytics. 2021 Academic Article GET IT
-
Systematic Review - Neuroprotection of ketosis in acute injury of the mammalian central nervous system: A meta-analysis.
Journal of neurochemistry.
2021
Review
GET IT
Times cited: 10 -
Percutaneous and Open Tracheostomy in Patients with COVID-19: Comparison and Outcomes of an Institutional Series in New York City.
Annals of surgery.
2021
Academic Article
GET IT
Times cited: 12 -
Tricuspid Stenosis in Pregnancy: A Valve-in-Valve Conundrum.
2020
GET IT
Times cited: 4 -
National trends and perioperative outcomes of robotic resection of thymic tumours in the United States: a propensity matching comparison with open and video-assisted thoracoscopic approaches†.
European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
2019
Academic Article
GET IT
Times cited: 25 -
Human CAR T cells with cell-intrinsic PD-1 checkpoint blockade resist tumor-mediated inhibition.
The Journal of clinical investigation.
2016
Academic Article
GET IT
Times cited: 862 -
Nuclear estrogen receptor-α expression is an independent predictor of recurrence in male patients with pT1aN0 lung adenocarcinomas, and correlates with regulatory T-cell infiltration.
Oncotarget.
2015
Academic Article
GET IT
Times cited: 25 -
Tumoral CD10 expression correlates with high-grade histology and increases risk of recurrence in patients with stage I lung adenocarcinoma.
Lung cancer (Amsterdam, Netherlands).
2015
Academic Article
GET IT
Times cited: 13 -
Tumoral CD10 expression correlates with aggressive histology and prognosis in patients with malignant pleural mesothelioma.
Annals of surgical oncology.
2015
Academic Article
GET IT
Times cited: 12 -
Regional delivery of mesothelin-targeted CAR T cell therapy generates potent and long-lasting CD4-dependent tumor immunity.
Science translational medicine.
2014
Academic Article
GET IT
Times cited: 481 -
Cisplatin-induced antitumor immunomodulation: a review of preclinical and clinical evidence.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2014
Information Resource
GET IT
Times cited: 291 -
Prognostic significance of adenocarcinoma in situ, minimally invasive adenocarcinoma, and nonmucinous lepidic predominant invasive adenocarcinoma of the lung in patients with stage I disease.
The American journal of surgical pathology.
2014
Academic Article
GET IT
Times cited: 220 -
Mesothelin overexpression is a marker of tumor aggressiveness and is associated with reduced recurrence-free and overall survival in early-stage lung adenocarcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2013
Academic Article
GET IT
Times cited: 142 - Mesothelin-targeted immunotherapies for malignant pleural mesothelioma. Annals of cardiothoracic surgery. 2012 Academic Article GET IT
-
Safety and stability of retrovirally transduced chimeric antigen receptor T cells.
Immunotherapy.
2012
Article
GET IT
Times cited: 11